Cellular effects of transferrin coordinated to [Cl(NH3)5Ru]Cl2 and cis-[Cl2(NH3)4Ru]Cl

被引:26
作者
Frasca, DR [1 ]
Gehrig, LE [1 ]
Clarke, MJ [1 ]
机构
[1] Boston Coll, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA
关键词
ruthenium; DNA; transferrin; toxicity; anticancer;
D O I
10.1016/S0162-0134(00)00180-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Estimates of the net equilibrium binding constants for [(H2O)(NH3)(5)Ru-II](2+), [Cl(NH3)(5)Ru-III](2+), cis-[(H2O)(2)(NH3)(4)Ru-II](2+) and cis-[Cl-2(NH3)(4)Ru-III](+) with apotransferrin (TF) and holotransferrin (Fe2Tf) suggests that Ru-III, but not Ru-II complexes bind with a higher affinity to the iron binding sites. Several other presumably histidyl imidazole sites bind with approximately the same affinity (K-eff = 10(2) to 10(3) M-1) to both Ru-II and Ru-III. Compared to HeLa cells, an order of magnitude higher level of nuclear DNA binding ([Ru](DNA)/[P](DNA)) was required to achieve the same level of toxicity in Jurkat T-ag cells, which probably relates to the substantially higher levels of cis-[Cl-2(NH3)(4)Ru](-) needed to inhibit 50% of the cell growth in the Jurkat T-ag cell line. Against Jurkat T-ag cells, the toxicity of the pentaammineruthenium(III) group is enhanced by approximately two orders of magnitude upon binding primarily to the Fe-sites in apotransferrin. whereas the toxicity of the tetraammineruthenium(III) moiety is only marginally increased. Binding to Fe2Tf does not increase the toxicity of either group. Significant dissociation over 24 h of the ammineruthenium(III) ions From apotransferrin requires reduction to Ru-II. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:139 / 149
页数:11
相关论文
共 38 条
[1]  
AISEN P, 1973, INORGANIC BIOCH, P280
[2]   H-1-NMR STUDY OF THE SOLVOLYSIS OF THE PARAMAGNETIC TETRACHLORO-BIS(IMIDAZOLE)RUTHENIUM(III) ANION IN WATER, METHANOL, AND DIMETHYL-SULFOXIDE [J].
ANDERSON, C ;
BEAUCHAMP, AL .
CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1995, 73 (04) :471-482
[3]   MOLECULAR-STRUCTURE OF SERUM TRANSFERRIN AT 3.3-A RESOLUTION [J].
BAILEY, S ;
EVANS, RW ;
GARRATT, RC ;
GORINSKY, B ;
HASNAIN, S ;
HORSBURGH, C ;
JHOTI, H ;
LINDLEY, PF ;
MYDIN, A ;
SARRA, R ;
WATSON, JL .
BIOCHEMISTRY, 1988, 27 (15) :5804-5812
[4]   Synthesis and immunosuppressive activity of ruthenium complexes [J].
Bastos, CM ;
Gordon, KA ;
Ocain, TD .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (02) :147-150
[5]  
BATES GC, 1982, J BIOL CHEM, V25, P7560
[7]  
CLARK MJ, 1995, HDB METAL LIGAND INT, V2, P1010
[8]  
Clarke M. J., 1980, ACS SYM SER, V190, P157
[9]  
Clarke M. J., 1980, MET IONS BIOL SYST, V11, P231
[10]  
Clarke MJ, 1996, MET IONS BIOL SYST, V32, P727